BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10374972)

  • 1. In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee.
    Heijtink R; Paulij W; van Bergen P; van Roosmalen M; Rohm D; Eichentopf B; Muchmore E; de Man R; Osterhaus A
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1529-1535. PubMed ID: 10374972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay.
    Heijtink RA; Kruining J; Weber YA; de Man RA; Schalm SW
    Hepatology; 1995 Oct; 22(4 Pt 1):1078-83. PubMed ID: 7557854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
    Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
    J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
    Liu Y; Zhang L; Zhou JY; Pan J; Hu W; Zhou YH
    PLoS One; 2016; 11(1):e0146980. PubMed ID: 26751075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    Fu X; Chen J; Chen H; Lin J; Xun Z; Li S; Liu C; Zeng Y; Chen T; Yang B; Ou Q
    J Med Virol; 2017 Aug; 89(8):1419-1426. PubMed ID: 28198078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen.
    Wang YM; Ng WC; Lo SK
    J Gastroenterol; 1999 Oct; 34(5):600-6. PubMed ID: 10535488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
    de Niet A; Jansen L; Zaaijer HL; Klause U; Takkenberg B; Janssen HL; Chu T; Petric R; Reesink HW
    Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.
    Pancher M; Désiré N; Ngo Y; Akhavan S; Pallier C; Poynard T; Thibault V
    J Clin Virol; 2015 Jan; 62():32-7. PubMed ID: 25542467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs.
    Zhou YH; Zhou J; Li L; Bi Y; Liu Y; Pan J; Wu C
    J Clin Virol; 2009 Dec; 46(4):363-6. PubMed ID: 19782639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antibody to the "y" determinant of HBsAg in a chimpanzee carrier of HBsAg subtype "adw".
    Tabor E; Gerety RJ; Smallwood LA; Barker LF
    J Immunol; 1976 Nov; 117(5 Pt.2):2038-40. PubMed ID: 62804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region.
    Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M
    Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
    Zhang XD; Ren S; Yu HB; Liu YL; Jin Y; Huang YX; Chen JM; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):674-7. PubMed ID: 22152382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.